CAPR
Capricor Therapeutics Inc
8.40$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.0% | -286.5% | -495.3% | -1,040.9% | -829.4% | -678.7% | -3,240.9% | -6,863.8% | 192.7% | -101.7% | -179.6% | – | |
| 1.0% | 2.9% | 3.9% | 10.5% | 9.4% | 17.1% | 46.4% | 100.3% | 20.9% | 4.2% | 6.4% | – | |
| 11.9% | 41.7% | 61.5% | 125.1% | 103.2% | 69.7% | 629.4% | 1,211.0% | 174.7% | 29.4% | 43.8% | – | |
| 11.9% | 41.7% | 108.5% | 125.1% | 103.2% | 70.0% | 629.4% | 1,137.3% | 176.1% | – | – | – | |
| 159.3% | 9.4% | -18.3% | -209.4% | -33.2% | -5.5% | 485.3% | 74.5% | 1,126.7% | -46.7% | -48.4% | – | |
| 4.5% | 4.0% | 6.1% | 2.4% | 18.9% | 54.5% | 176.5% | 488.5% | 131.7% | 8.1% | 6.9% | – | |
| 3.4% | -215.6% | -162.7% | 364.4% | 279.5% | -298.7% | 1,753.2% | -488.5% | -1,374.6% | 20.3% | -521.7% | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.1% | 436.7% | 435.1% | 810.4% | 410.1% | 0.0% | 10,657.2% | 8,258.5% | 191.0% | – | – | – | |
| 124.8% | 125.8% | 148.9% | 36.6% | 19.0% | 31.7% | 102.5% | 0.0% | – | – | – | – | |
| 124.9% | 436.7% | 584.0% | 847.0% | 410.1% | 913.2% | 10,759.8% | 8,258.5% | 191.0% | 101.6% | 686.0% | – | |
| 151.3% | -65.3% | -74.1% | 170.5% | -139.8% | -64.3% | 9,272.1% | 906.3% | -990.9% | 20.2% | -15.3% | – | |
| 18.5% | -290.5% | -501.4% | -1,043.2% | -848.3% | -678.7% | -3,417.4% | -7,352.3% | 61.0% | -109.8% | -186.5% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.